Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea · Delayed Price · Currency is KRW 27,800
-650 (-2.28%)
May 15, 2026, 10:58 AM KST
Daihan Pharmaceutical Market Cap
Daihan Pharmaceutical has a market cap or net worth of 167.29 billion as of May 14, 2026. Its market cap has increased by 10.06% in one year.
Market Cap
167.29B
Enterprise Value
77.76B
Revenue
208.61B
Ranking
n/a
PE Ratio
6.05
Stock Price
27,800.00
Market Cap Chart
Since March 1, 2001, Daihan Pharmaceutical's market cap has increased from 22.26B to 167.29B, an increase of 651.51%. That is a compound annual growth rate of 8.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 167.29B | -2.74% |
| Dec 30, 2025 | 171.99B | 11.64% |
| Dec 30, 2024 | 154.06B | -5.59% |
| Dec 28, 2023 | 163.17B | -11.13% |
| Dec 29, 2022 | 183.60B | 6.62% |
| Dec 30, 2021 | 172.20B | -12.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AptaBio Therapeutics | 202.83B |
| Jeil Pharmaceutical Co.,Ltd | 192.78B |
| JW Lifescience | 192.32B |
| Samil Pharmaceutical Co.,Ltd | 186.18B |
| Ilyang Pharmaceutical Co.,Ltd | 178.71B |
| SAMSUNG PHARM. Co., LTD. | 170.36B |
| Hana Pharm | 164.76B |
| Dongwha Pharm.Co.,Ltd | 162.43B |